Article ID Journal Published Year Pages File Type
8243679 International Journal of Radiation Oncology*Biology*Physics 2006 8 Pages PDF
Abstract
Conclusion: This study did not show a survival benefit of CCRT with weekly cisplatin and HDRICB for Stage II-III cervical cancer, nor did it demonstrate a significant increase of late complications when comparing with RT alone.
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Authors
, , , , , , , , ,